trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['trastuzumab']
i just uploaded asco 2022: trastuzumab deruxtecan vs. treatment of physician's choice in her2-low unresectable a 
Conference reports (Webcasts, Slides & Videos) in German and English about clinical oncology